| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 198 | 2024 | 2401 | 23.200 |
Why?
|
| Androgens | 58 | 2023 | 1271 | 9.980 |
Why?
|
| Hypogonadism | 43 | 2024 | 798 | 9.580 |
Why?
|
| Hormone Replacement Therapy | 37 | 2024 | 744 | 6.040 |
Why?
|
| Muscle Strength | 28 | 2024 | 586 | 4.680 |
Why?
|
| Anabolic Agents | 14 | 2023 | 247 | 4.670 |
Why?
|
| Mobility Limitation | 19 | 2021 | 405 | 4.460 |
Why?
|
| Sarcopenia | 17 | 2024 | 368 | 4.130 |
Why?
|
| Myostatin | 19 | 2024 | 124 | 3.480 |
Why?
|
| Sex Hormone-Binding Globulin | 32 | 2023 | 548 | 3.450 |
Why?
|
| Muscle, Skeletal | 55 | 2023 | 4933 | 3.380 |
Why?
|
| Receptors, Androgen | 20 | 2023 | 1057 | 2.980 |
Why?
|
| Body Composition | 34 | 2020 | 2400 | 2.940 |
Why?
|
| Hand Strength | 13 | 2023 | 444 | 2.700 |
Why?
|
| Aging | 47 | 2023 | 8626 | 2.490 |
Why?
|
| Erectile Dysfunction | 7 | 2024 | 459 | 2.200 |
Why?
|
| Estrone | 11 | 2022 | 239 | 2.140 |
Why?
|
| Estradiol | 23 | 2022 | 2021 | 1.980 |
Why?
|
| Dihydrotestosterone | 8 | 2022 | 188 | 1.920 |
Why?
|
| Accidental Falls | 10 | 2020 | 1057 | 1.830 |
Why?
|
| Gonadal Steroid Hormones | 12 | 2024 | 711 | 1.770 |
Why?
|
| Erythropoiesis | 6 | 2020 | 705 | 1.770 |
Why?
|
| Endocrine System Diseases | 6 | 2019 | 248 | 1.690 |
Why?
|
| Dietary Proteins | 5 | 2021 | 963 | 1.550 |
Why?
|
| Tandem Mass Spectrometry | 8 | 2022 | 1157 | 1.360 |
Why?
|
| Double-Blind Method | 54 | 2024 | 12017 | 1.340 |
Why?
|
| Male | 245 | 2024 | 349538 | 1.320 |
Why?
|
| Chromatography, Liquid | 8 | 2022 | 977 | 1.280 |
Why?
|
| Aged | 148 | 2024 | 162944 | 1.260 |
Why?
|
| Performance-Enhancing Substances | 3 | 2017 | 29 | 1.180 |
Why?
|
| Doping in Sports | 3 | 2021 | 63 | 1.170 |
Why?
|
| Nicotinamide Mononucleotide | 2 | 2023 | 17 | 1.130 |
Why?
|
| Cardiovascular System | 4 | 2022 | 827 | 1.100 |
Why?
|
| Finasteride | 2 | 2017 | 89 | 1.100 |
Why?
|
| Consensus | 10 | 2024 | 2935 | 1.090 |
Why?
|
| Anemia | 4 | 2023 | 1499 | 1.060 |
Why?
|
| Body Dysmorphic Disorders | 3 | 2019 | 229 | 1.060 |
Why?
|
| Humans | 292 | 2024 | 742088 | 1.060 |
Why?
|
| Activin Receptors, Type II | 3 | 2017 | 127 | 1.050 |
Why?
|
| 5-alpha Reductase Inhibitors | 3 | 2017 | 106 | 1.030 |
Why?
|
| Cardiovascular Diseases | 23 | 2024 | 15108 | 1.030 |
Why?
|
| Diagnostic Techniques, Endocrine | 3 | 2018 | 45 | 1.030 |
Why?
|
| Independent Living | 12 | 2022 | 564 | 1.030 |
Why?
|
| NAD | 3 | 2023 | 594 | 1.020 |
Why?
|
| Muscle Weakness | 5 | 2020 | 414 | 0.970 |
Why?
|
| Prostatic Neoplasms | 9 | 2023 | 11039 | 0.940 |
Why?
|
| Fatty Liver | 3 | 2023 | 728 | 0.920 |
Why?
|
| Erythropoietin | 5 | 2016 | 724 | 0.910 |
Why?
|
| Growth Differentiation Factors | 6 | 2024 | 98 | 0.900 |
Why?
|
| Absorptiometry, Photon | 12 | 2024 | 1726 | 0.900 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2022 | 32 | 0.890 |
Why?
|
| Alopecia | 2 | 2017 | 381 | 0.880 |
Why?
|
| Human Growth Hormone | 9 | 2013 | 683 | 0.880 |
Why?
|
| Urinary Retention | 1 | 2023 | 110 | 0.880 |
Why?
|
| Satellite Cells, Skeletal Muscle | 5 | 2012 | 124 | 0.880 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 2414 | 0.870 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 2 | 2013 | 101 | 0.830 |
Why?
|
| Reproduction | 4 | 2015 | 668 | 0.830 |
Why?
|
| Sexual Dysfunction, Physiological | 7 | 2018 | 357 | 0.810 |
Why?
|
| Insulin Resistance | 14 | 2023 | 3861 | 0.800 |
Why?
|
| Exercise Test | 10 | 2020 | 2075 | 0.800 |
Why?
|
| Polycythemia | 3 | 2013 | 126 | 0.800 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2017 | 570 | 0.790 |
Why?
|
| Bone Density | 9 | 2024 | 3469 | 0.760 |
Why?
|
| Middle Aged | 105 | 2024 | 213127 | 0.760 |
Why?
|
| Receptors, LDL | 3 | 2013 | 475 | 0.750 |
Why?
|
| Simian immunodeficiency virus | 2 | 2017 | 846 | 0.730 |
Why?
|
| Body Mass Index | 24 | 2023 | 12695 | 0.730 |
Why?
|
| Sulfones | 2 | 2013 | 437 | 0.730 |
Why?
|
| Klinefelter Syndrome | 1 | 2020 | 49 | 0.720 |
Why?
|
| Endocrinology | 2 | 2018 | 443 | 0.710 |
Why?
|
| Postmenopause | 11 | 2022 | 2461 | 0.710 |
Why?
|
| Transforming Growth Factor beta | 11 | 2023 | 2006 | 0.700 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2013 | 362 | 0.690 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2020 | 364 | 0.690 |
Why?
|
| HIV Wasting Syndrome | 3 | 2014 | 97 | 0.670 |
Why?
|
| Hemoglobins | 7 | 2023 | 1532 | 0.660 |
Why?
|
| Geriatric Assessment | 7 | 2020 | 1369 | 0.660 |
Why?
|
| Prediabetic State | 1 | 2024 | 493 | 0.650 |
Why?
|
| Arteriosclerosis | 3 | 2013 | 1092 | 0.650 |
Why?
|
| Prostate-Specific Antigen | 7 | 2023 | 2458 | 0.650 |
Why?
|
| Gonadotropins | 3 | 2013 | 241 | 0.650 |
Why?
|
| Walking | 7 | 2021 | 1177 | 0.630 |
Why?
|
| Body Weight | 14 | 2023 | 4664 | 0.630 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2007 | 555 | 0.620 |
Why?
|
| Sexual Behavior | 8 | 2024 | 2050 | 0.620 |
Why?
|
| Veterans Health | 1 | 2019 | 216 | 0.620 |
Why?
|
| Fractures, Bone | 4 | 2024 | 1945 | 0.620 |
Why?
|
| Adipose Tissue | 13 | 2015 | 3278 | 0.620 |
Why?
|
| Physical Fitness | 4 | 2020 | 732 | 0.610 |
Why?
|
| Behavior Therapy | 1 | 2023 | 866 | 0.610 |
Why?
|
| Exercise | 7 | 2023 | 5611 | 0.590 |
Why?
|
| Adipocytes | 5 | 2008 | 1182 | 0.580 |
Why?
|
| Dose-Response Relationship, Drug | 24 | 2019 | 10943 | 0.580 |
Why?
|
| Patient Care Management | 1 | 2020 | 306 | 0.580 |
Why?
|
| Gels | 10 | 2024 | 427 | 0.560 |
Why?
|
| Estrogens | 7 | 2022 | 1562 | 0.560 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 591 | 0.560 |
Why?
|
| Muscle Fatigue | 3 | 2008 | 82 | 0.560 |
Why?
|
| Reference Values | 13 | 2022 | 4982 | 0.560 |
Why?
|
| Physical Endurance | 6 | 2009 | 370 | 0.550 |
Why?
|
| Aged, 80 and over | 49 | 2023 | 57683 | 0.540 |
Why?
|
| Prostate | 5 | 2023 | 1764 | 0.540 |
Why?
|
| Adult | 94 | 2024 | 213712 | 0.540 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 930 | 0.540 |
Why?
|
| Hysterectomy | 4 | 2019 | 927 | 0.540 |
Why?
|
| Eating | 1 | 2022 | 1535 | 0.520 |
Why?
|
| beta Catenin | 4 | 2012 | 1058 | 0.520 |
Why?
|
| Erythrocyte Deformability | 1 | 2015 | 56 | 0.520 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 546 | 0.510 |
Why?
|
| Body Fat Distribution | 2 | 2006 | 244 | 0.510 |
Why?
|
| Weight Loss | 8 | 2009 | 2604 | 0.500 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 187 | 0.500 |
Why?
|
| Blood Viscosity | 1 | 2015 | 124 | 0.500 |
Why?
|
| Sexuality | 3 | 2014 | 174 | 0.500 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1060 | 0.490 |
Why?
|
| Androgen Antagonists | 5 | 2023 | 1350 | 0.490 |
Why?
|
| Reproductive Medicine | 1 | 2016 | 108 | 0.490 |
Why?
|
| Follistatin | 6 | 2024 | 141 | 0.470 |
Why?
|
| Joints | 1 | 2015 | 326 | 0.470 |
Why?
|
| Motor Activity | 7 | 2015 | 2714 | 0.470 |
Why?
|
| Luteinizing Hormone | 9 | 2023 | 864 | 0.460 |
Why?
|
| Leuprolide | 4 | 2010 | 303 | 0.450 |
Why?
|
| Renal Dialysis | 1 | 2022 | 1780 | 0.450 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2024 | 838 | 0.450 |
Why?
|
| Receptors, Fc | 1 | 2017 | 540 | 0.450 |
Why?
|
| Disabled Persons | 1 | 2023 | 1209 | 0.450 |
Why?
|
| Epidemics | 1 | 2019 | 521 | 0.440 |
Why?
|
| Bone Resorption | 1 | 2017 | 722 | 0.440 |
Why?
|
| Quality of Life | 11 | 2023 | 12730 | 0.440 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2014 | 279 | 0.430 |
Why?
|
| Growth Hormone | 3 | 2010 | 703 | 0.430 |
Why?
|
| Wnt Proteins | 2 | 2008 | 721 | 0.430 |
Why?
|
| Prostatectomy | 1 | 2021 | 1871 | 0.430 |
Why?
|
| Administration, Cutaneous | 10 | 2020 | 711 | 0.420 |
Why?
|
| Piperazines | 2 | 2013 | 2488 | 0.420 |
Why?
|
| Work Schedule Tolerance | 1 | 2016 | 565 | 0.420 |
Why?
|
| Azasteroids | 1 | 2012 | 37 | 0.420 |
Why?
|
| Hematocrit | 5 | 2014 | 636 | 0.410 |
Why?
|
| Overweight | 1 | 2023 | 2366 | 0.410 |
Why?
|
| Body Image | 1 | 2017 | 609 | 0.410 |
Why?
|
| India | 17 | 2018 | 2187 | 0.410 |
Why?
|
| Cross-Sectional Studies | 31 | 2024 | 24913 | 0.400 |
Why?
|
| Public Health | 2 | 2022 | 2594 | 0.400 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 171 | 0.400 |
Why?
|
| Cross Infection | 1 | 2020 | 1413 | 0.400 |
Why?
|
| Chemistry, Clinical | 1 | 2011 | 64 | 0.390 |
Why?
|
| Hip Fractures | 4 | 2020 | 954 | 0.390 |
Why?
|
| Heart | 2 | 2023 | 4462 | 0.380 |
Why?
|
| Health Status | 4 | 2018 | 4030 | 0.380 |
Why?
|
| Monocytes | 1 | 2020 | 2593 | 0.380 |
Why?
|
| Certification | 1 | 2014 | 423 | 0.380 |
Why?
|
| Atherosclerosis | 5 | 2018 | 3428 | 0.370 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1436 | 0.370 |
Why?
|
| Female | 91 | 2024 | 379592 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 16 | 2023 | 21821 | 0.370 |
Why?
|
| Placebos | 10 | 2018 | 1677 | 0.370 |
Why?
|
| Health Promotion | 1 | 2022 | 2194 | 0.360 |
Why?
|
| Penile Erection | 3 | 2022 | 97 | 0.360 |
Why?
|
| Occupational Health | 1 | 2016 | 809 | 0.360 |
Why?
|
| TCF Transcription Factors | 3 | 2008 | 140 | 0.360 |
Why?
|
| Muscle Development | 6 | 2020 | 271 | 0.360 |
Why?
|
| Gonadotropin-Releasing Hormone | 5 | 2008 | 1185 | 0.350 |
Why?
|
| Societies, Medical | 3 | 2021 | 3740 | 0.350 |
Why?
|
| Obesity | 12 | 2023 | 12705 | 0.350 |
Why?
|
| Erythrocytes | 3 | 2015 | 2452 | 0.350 |
Why?
|
| Orchiectomy | 6 | 2015 | 466 | 0.350 |
Why?
|
| Exercise Therapy | 4 | 2023 | 904 | 0.350 |
Why?
|
| Iron | 2 | 2020 | 1773 | 0.350 |
Why?
|
| Blood Platelets | 1 | 2020 | 2506 | 0.350 |
Why?
|
| Sports | 3 | 2021 | 686 | 0.340 |
Why?
|
| Adipogenesis | 3 | 2009 | 358 | 0.340 |
Why?
|
| Procollagen | 1 | 2009 | 185 | 0.340 |
Why?
|
| Lipolysis | 2 | 2009 | 211 | 0.340 |
Why?
|
| Animals | 48 | 2023 | 168561 | 0.330 |
Why?
|
| Hepatocytes | 2 | 2013 | 1209 | 0.330 |
Why?
|
| Puberty | 2 | 2009 | 489 | 0.330 |
Why?
|
| Regeneration | 2 | 2020 | 1485 | 0.320 |
Why?
|
| Dependovirus | 1 | 2013 | 706 | 0.320 |
Why?
|
| Pluripotent Stem Cells | 3 | 2004 | 795 | 0.320 |
Why?
|
| Treatment Outcome | 27 | 2022 | 62966 | 0.310 |
Why?
|
| Frail Elderly | 4 | 2019 | 691 | 0.310 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1333 | 0.310 |
Why?
|
| Nuclear Family | 1 | 2009 | 318 | 0.310 |
Why?
|
| Neutrophils | 1 | 2020 | 3711 | 0.310 |
Why?
|
| Ritonavir | 1 | 2009 | 322 | 0.310 |
Why?
|
| Ligands | 5 | 2017 | 3293 | 0.300 |
Why?
|
| Smad3 Protein | 1 | 2008 | 180 | 0.300 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2016 | 997 | 0.300 |
Why?
|
| HIV Infections | 11 | 2021 | 16678 | 0.300 |
Why?
|
| Insulin | 9 | 2019 | 6575 | 0.300 |
Why?
|
| Educational Measurement | 1 | 2014 | 1206 | 0.290 |
Why?
|
| Adiposity | 3 | 2012 | 1806 | 0.290 |
Why?
|
| HIV Protease Inhibitors | 1 | 2009 | 430 | 0.290 |
Why?
|
| Lipids | 9 | 2013 | 3302 | 0.290 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 3800 | 0.290 |
Why?
|
| Puberty, Delayed | 1 | 2007 | 115 | 0.280 |
Why?
|
| Dehydroepiandrosterone | 2 | 2006 | 252 | 0.280 |
Why?
|
| Prevalence | 13 | 2023 | 15194 | 0.280 |
Why?
|
| Libido | 5 | 2018 | 121 | 0.280 |
Why?
|
| Affect | 3 | 2018 | 1473 | 0.280 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 148 | 0.280 |
Why?
|
| Oxandrolone | 1 | 2006 | 23 | 0.280 |
Why?
|
| Natriuretic Peptides | 3 | 2011 | 150 | 0.270 |
Why?
|
| Muscular Atrophy | 3 | 2003 | 350 | 0.270 |
Why?
|
| Mice | 30 | 2023 | 81045 | 0.270 |
Why?
|
| Hyperprolactinemia | 1 | 2007 | 129 | 0.270 |
Why?
|
| Reference Standards | 2 | 2022 | 1020 | 0.270 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.270 |
Why?
|
| Thigh | 3 | 2020 | 247 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2014 | 3915 | 0.270 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3748 | 0.270 |
Why?
|
| Nandrolone | 1 | 2005 | 17 | 0.270 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2400 | 0.270 |
Why?
|
| Blood Chemical Analysis | 2 | 2018 | 440 | 0.270 |
Why?
|
| Autophagy | 1 | 2013 | 1301 | 0.260 |
Why?
|
| Recombinant Proteins | 5 | 2013 | 6608 | 0.260 |
Why?
|
| Fertility | 3 | 2021 | 770 | 0.260 |
Why?
|
| Child of Impaired Parents | 1 | 2009 | 455 | 0.260 |
Why?
|
| United States | 22 | 2023 | 69693 | 0.260 |
Why?
|
| Risk Assessment | 10 | 2022 | 23320 | 0.260 |
Why?
|
| Young Adult | 23 | 2023 | 56350 | 0.260 |
Why?
|
| Mental Health | 2 | 2023 | 2997 | 0.250 |
Why?
|
| Abdominal Fat | 1 | 2006 | 223 | 0.250 |
Why?
|
| Cognition | 7 | 2019 | 6722 | 0.250 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2062 | 0.250 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2009 | 369 | 0.250 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.250 |
Why?
|
| Organ Size | 9 | 2015 | 2253 | 0.250 |
Why?
|
| Weight Lifting | 3 | 2017 | 131 | 0.250 |
Why?
|
| Gene Expression Regulation | 11 | 2018 | 12071 | 0.240 |
Why?
|
| Dietary Supplements | 3 | 2018 | 3294 | 0.240 |
Why?
|
| Diabetes Complications | 2 | 2012 | 1359 | 0.240 |
Why?
|
| Liver | 5 | 2013 | 7470 | 0.240 |
Why?
|
| Infertility, Male | 1 | 2007 | 407 | 0.230 |
Why?
|
| Receptors, Transferrin | 2 | 2020 | 296 | 0.230 |
Why?
|
| Biological Specimen Banks | 4 | 2022 | 707 | 0.230 |
Why?
|
| Clinical Trials as Topic | 5 | 2023 | 7901 | 0.230 |
Why?
|
| Cell Nucleus | 5 | 2008 | 2968 | 0.230 |
Why?
|
| Pyrazines | 1 | 2009 | 1231 | 0.230 |
Why?
|
| Organ Specificity | 4 | 2016 | 2003 | 0.230 |
Why?
|
| Muscle Proteins | 5 | 2012 | 1159 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2010 | 2014 | 0.220 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 3 | 2012 | 62 | 0.220 |
Why?
|
| Hypertrophy | 3 | 2015 | 568 | 0.220 |
Why?
|
| Muscle Contraction | 3 | 2008 | 1241 | 0.220 |
Why?
|
| Prostatic Diseases | 1 | 2003 | 56 | 0.220 |
Why?
|
| Fatigue | 3 | 2018 | 1526 | 0.220 |
Why?
|
| Leg | 3 | 2008 | 1110 | 0.220 |
Why?
|
| Age Factors | 11 | 2020 | 18355 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2022 | 9941 | 0.220 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 3611 | 0.220 |
Why?
|
| Risk Factors | 23 | 2022 | 72145 | 0.220 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4250 | 0.210 |
Why?
|
| Myosin Heavy Chains | 5 | 2019 | 414 | 0.210 |
Why?
|
| Chromosome Deletion | 1 | 2007 | 1400 | 0.210 |
Why?
|
| Population Groups | 1 | 2003 | 208 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2023 | 2203 | 0.210 |
Why?
|
| Goiter, Endemic | 1 | 2001 | 3 | 0.210 |
Why?
|
| Incidence | 10 | 2022 | 20928 | 0.210 |
Why?
|
| Heart Injuries | 1 | 2023 | 209 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 11695 | 0.200 |
Why?
|
| Research Design | 4 | 2017 | 5979 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2283 | 0.200 |
Why?
|
| Chronic Disease | 3 | 2023 | 9144 | 0.200 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2003 | 138 | 0.200 |
Why?
|
| Spinal Fractures | 2 | 2019 | 698 | 0.200 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 42 | 0.200 |
Why?
|
| Oxygen Consumption | 3 | 2018 | 1869 | 0.200 |
Why?
|
| Iodine | 2 | 2001 | 285 | 0.200 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.200 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2009 | 1625 | 0.200 |
Why?
|
| Peptide Fragments | 3 | 2011 | 5095 | 0.200 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2011 | 238 | 0.190 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 38 | 0.190 |
Why?
|
| Blood Glucose | 7 | 2021 | 6249 | 0.190 |
Why?
|
| Adolescent | 25 | 2023 | 85649 | 0.190 |
Why?
|
| Radius | 1 | 2024 | 422 | 0.190 |
Why?
|
| Cell Differentiation | 10 | 2020 | 11470 | 0.190 |
Why?
|
| Sleep | 1 | 2016 | 4604 | 0.190 |
Why?
|
| Gene Expression | 7 | 2020 | 7790 | 0.190 |
Why?
|
| HIV | 1 | 2008 | 1600 | 0.190 |
Why?
|
| Signal Transduction | 13 | 2023 | 23387 | 0.190 |
Why?
|
| Sperm Retrieval | 1 | 2020 | 23 | 0.180 |
Why?
|
| Erythrocyte Count | 1 | 2020 | 163 | 0.180 |
Why?
|
| Testosterone Congeners | 2 | 2023 | 62 | 0.180 |
Why?
|
| Erythroblasts | 1 | 2020 | 150 | 0.180 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2513 | 0.180 |
Why?
|
| Mortality | 3 | 2021 | 2857 | 0.180 |
Why?
|
| Gene Deletion | 3 | 2019 | 2751 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2023 | 780 | 0.170 |
Why?
|
| Patients | 2 | 2020 | 892 | 0.170 |
Why?
|
| GATA1 Transcription Factor | 1 | 2020 | 293 | 0.170 |
Why?
|
| Macaca mulatta | 2 | 2017 | 2378 | 0.170 |
Why?
|
| Administration, Topical | 3 | 2024 | 688 | 0.170 |
Why?
|
| Metabolome | 2 | 2023 | 881 | 0.170 |
Why?
|
| Ovariectomy | 4 | 2015 | 660 | 0.170 |
Why?
|
| Hormones | 3 | 2022 | 884 | 0.170 |
Why?
|
| Sex Education | 1 | 1999 | 93 | 0.170 |
Why?
|
| Erythroid Cells | 1 | 2020 | 238 | 0.170 |
Why?
|
| Sports Medicine | 1 | 2021 | 225 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4751 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2022 | 1202 | 0.160 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4628 | 0.160 |
Why?
|
| Prospective Studies | 12 | 2023 | 53187 | 0.160 |
Why?
|
| Nurse's Role | 1 | 2020 | 209 | 0.160 |
Why?
|
| Inflammation | 3 | 2016 | 10578 | 0.160 |
Why?
|
| Patient Selection | 3 | 2018 | 4214 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2022 | 1813 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2014 | 4681 | 0.160 |
Why?
|
| RNA, Messenger | 9 | 2015 | 13029 | 0.160 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11690 | 0.160 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1997 | 28 | 0.160 |
Why?
|
| Tibia | 1 | 2024 | 1075 | 0.160 |
Why?
|
| Transcortin | 1 | 2017 | 13 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 2231 | 0.150 |
Why?
|
| Cohort Studies | 13 | 2022 | 40450 | 0.150 |
Why?
|
| Muscles | 2 | 2015 | 1617 | 0.150 |
Why?
|
| Aromatase | 1 | 2018 | 146 | 0.150 |
Why?
|
| Follicle Stimulating Hormone, Human | 2 | 2008 | 25 | 0.150 |
Why?
|
| Transsexualism | 2 | 2023 | 177 | 0.150 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 874 | 0.150 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 462 | 0.150 |
Why?
|
| Neoplasms | 3 | 2023 | 21596 | 0.150 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2018 | 187 | 0.150 |
Why?
|
| Smoke | 1 | 2019 | 226 | 0.150 |
Why?
|
| Cholesterol | 2 | 2023 | 2895 | 0.150 |
Why?
|
| Diet | 3 | 2018 | 7923 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2020 | 2924 | 0.150 |
Why?
|
| Hip Joint | 1 | 2004 | 1002 | 0.150 |
Why?
|
| Soybean Proteins | 1 | 2017 | 60 | 0.150 |
Why?
|
| Spleen | 2 | 2013 | 2359 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2023 | 1296 | 0.140 |
Why?
|
| Cause of Death | 4 | 2021 | 3571 | 0.140 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2012 | 1573 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 533 | 0.140 |
Why?
|
| Spine | 1 | 2004 | 1143 | 0.140 |
Why?
|
| Immunization Schedule | 1 | 1997 | 221 | 0.140 |
Why?
|
| Menopause | 3 | 2022 | 1621 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 455 | 0.140 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2008 | 154 | 0.140 |
Why?
|
| Glucose | 2 | 2024 | 4391 | 0.140 |
Why?
|
| Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
| Up-Regulation | 5 | 2014 | 4211 | 0.140 |
Why?
|
| Femoral Fractures | 1 | 2019 | 376 | 0.130 |
Why?
|
| Women's Health | 1 | 2005 | 2034 | 0.130 |
Why?
|
| Fluoroimmunoassay | 2 | 2013 | 33 | 0.130 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 1636 | 0.130 |
Why?
|
| Drug Labeling | 1 | 2017 | 231 | 0.130 |
Why?
|
| Radioimmunoassay | 2 | 2013 | 918 | 0.130 |
Why?
|
| Smad Proteins | 2 | 2013 | 162 | 0.130 |
Why?
|
| Veterans | 3 | 2018 | 2513 | 0.130 |
Why?
|
| Carotid Arteries | 1 | 2020 | 952 | 0.130 |
Why?
|
| Internationality | 2 | 2011 | 1002 | 0.130 |
Why?
|
| Extremities | 2 | 2015 | 865 | 0.130 |
Why?
|
| Minority Health | 1 | 2016 | 86 | 0.130 |
Why?
|
| Off-Label Use | 1 | 2016 | 169 | 0.130 |
Why?
|
| Self-Assessment | 1 | 2017 | 390 | 0.130 |
Why?
|
| Maternal-Child Health Centers | 1 | 1995 | 40 | 0.130 |
Why?
|
| Hospitals, Veterans | 1 | 2017 | 404 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 211 | 0.130 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1794 | 0.130 |
Why?
|
| Calcium | 3 | 2018 | 5753 | 0.130 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 154 | 0.120 |
Why?
|
| Random Allocation | 2 | 2013 | 2425 | 0.120 |
Why?
|
| Hypopituitarism | 2 | 2014 | 254 | 0.120 |
Why?
|
| Heart Failure | 3 | 2024 | 10856 | 0.120 |
Why?
|
| Drug Administration Schedule | 3 | 2010 | 4929 | 0.120 |
Why?
|
| Gait | 4 | 2022 | 784 | 0.120 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 39004 | 0.120 |
Why?
|
| Energy Intake | 2 | 2017 | 2147 | 0.120 |
Why?
|
| Infertility | 1 | 2021 | 655 | 0.120 |
Why?
|
| Impotence, Vasculogenic | 1 | 2013 | 11 | 0.120 |
Why?
|
| Eflornithine | 1 | 2013 | 31 | 0.120 |
Why?
|
| Attitude | 1 | 1999 | 772 | 0.120 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 63 | 0.120 |
Why?
|
| Metabolism | 1 | 2015 | 193 | 0.120 |
Why?
|
| Cathepsin L | 1 | 2013 | 75 | 0.120 |
Why?
|
| Hair | 1 | 2017 | 483 | 0.120 |
Why?
|
| Genes, Y-Linked | 1 | 2013 | 11 | 0.120 |
Why?
|
| Syndrome | 2 | 2010 | 3248 | 0.120 |
Why?
|
| Massachusetts | 6 | 2013 | 8662 | 0.120 |
Why?
|
| Hypertension | 4 | 2019 | 8455 | 0.120 |
Why?
|
| Athletes | 1 | 2021 | 1092 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 1402 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2016 | 738 | 0.110 |
Why?
|
| Glucocorticoids | 4 | 2009 | 2107 | 0.110 |
Why?
|
| 3T3 Cells | 2 | 2005 | 1101 | 0.110 |
Why?
|
| Malaria | 1 | 2003 | 1232 | 0.110 |
Why?
|
| Thinness | 3 | 2011 | 479 | 0.110 |
Why?
|
| Anthropometry | 5 | 2020 | 1350 | 0.110 |
Why?
|
| Disease Progression | 6 | 2020 | 13256 | 0.110 |
Why?
|
| Orgasm | 1 | 2012 | 64 | 0.110 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 146 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 851 | 0.110 |
Why?
|
| Growth | 1 | 1995 | 376 | 0.110 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2003 | 69 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2018 | 2680 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14554 | 0.110 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2020 | 1827 | 0.110 |
Why?
|
| Erythroid Precursor Cells | 1 | 2013 | 218 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 9735 | 0.110 |
Why?
|
| Cytokines | 2 | 2013 | 7317 | 0.110 |
Why?
|
| Self Care | 1 | 2018 | 786 | 0.110 |
Why?
|
| Kinetics | 4 | 2011 | 6474 | 0.110 |
Why?
|
| Sebum | 1 | 2012 | 16 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 392 | 0.110 |
Why?
|
| Commerce | 1 | 2017 | 591 | 0.110 |
Why?
|
| Models, Chemical | 1 | 2014 | 626 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2019 | 3306 | 0.100 |
Why?
|
| Drug Design | 2 | 2009 | 1078 | 0.100 |
Why?
|
| Coitus | 1 | 2012 | 133 | 0.100 |
Why?
|
| Sex Factors | 5 | 2020 | 10392 | 0.100 |
Why?
|
| Patient Advocacy | 1 | 2014 | 353 | 0.100 |
Why?
|
| Transferrin | 1 | 2013 | 295 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2015 | 575 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 5 | 2018 | 7276 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 126 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2012 | 10472 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 14720 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2020 | 1499 | 0.100 |
Why?
|
| Voice | 1 | 2015 | 259 | 0.100 |
Why?
|
| Flutamide | 1 | 2012 | 96 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2010 | 3001 | 0.100 |
Why?
|
| Drug Therapy, Combination | 4 | 2012 | 6483 | 0.100 |
Why?
|
| Teaching | 1 | 1999 | 1174 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2018 | 2407 | 0.100 |
Why?
|
| Thermodynamics | 2 | 2011 | 594 | 0.100 |
Why?
|
| Tendons | 1 | 2015 | 548 | 0.100 |
Why?
|
| K562 Cells | 1 | 2013 | 632 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2013 | 302 | 0.100 |
Why?
|
| Pelvic Floor | 2 | 2019 | 138 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2017 | 1181 | 0.100 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 2645 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 281 | 0.100 |
Why?
|
| Logistic Models | 4 | 2020 | 13403 | 0.100 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 1844 | 0.100 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 6454 | 0.100 |
Why?
|
| Models, Biological | 2 | 2009 | 9581 | 0.100 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2011 | 59 | 0.100 |
Why?
|
| Mutation | 2 | 2013 | 29717 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9410 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2372 | 0.090 |
Why?
|
| Athletic Performance | 1 | 2011 | 95 | 0.090 |
Why?
|
| Cell Count | 2 | 2006 | 1831 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7721 | 0.090 |
Why?
|
| Workload | 1 | 2016 | 849 | 0.090 |
Why?
|
| Skinfold Thickness | 1 | 1990 | 162 | 0.090 |
Why?
|
| Child Welfare | 1 | 1994 | 523 | 0.090 |
Why?
|
| Workplace | 1 | 2016 | 836 | 0.090 |
Why?
|
| Europe | 1 | 2017 | 3339 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 608 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2023 | 5019 | 0.090 |
Why?
|
| Time Factors | 6 | 2018 | 40054 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 841 | 0.090 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2009 | 16 | 0.090 |
Why?
|
| Habits | 1 | 2010 | 137 | 0.090 |
Why?
|
| Physicians | 2 | 2023 | 4554 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2017 | 1183 | 0.090 |
Why?
|
| Community Health Services | 1 | 1995 | 650 | 0.090 |
Why?
|
| Executive Function | 2 | 2017 | 1362 | 0.090 |
Why?
|
| Coronary Vessels | 3 | 2016 | 3099 | 0.090 |
Why?
|
| Calorimetry | 1 | 2009 | 126 | 0.090 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2009 | 21 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2014 | 971 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 1969 | 0.090 |
Why?
|
| Purines | 1 | 2012 | 593 | 0.090 |
Why?
|
| Mass Screening | 2 | 2003 | 5238 | 0.080 |
Why?
|
| Life Style | 4 | 2020 | 3824 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2013 | 1154 | 0.080 |
Why?
|
| HIV-1 | 1 | 2006 | 6934 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2006 | 11363 | 0.080 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2008 | 98 | 0.080 |
Why?
|
| Developing Countries | 1 | 2001 | 2789 | 0.080 |
Why?
|
| Azoospermia | 1 | 2008 | 27 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2011 | 19223 | 0.080 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 15056 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 894 | 0.080 |
Why?
|
| Immunoassay | 2 | 2011 | 752 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6365 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2015 | 1299 | 0.080 |
Why?
|
| Minority Groups | 1 | 2016 | 1215 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 1895 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2013 | 12164 | 0.080 |
Why?
|
| Arousal | 1 | 2014 | 1165 | 0.080 |
Why?
|
| PPAR gamma | 2 | 2009 | 493 | 0.080 |
Why?
|
| Nutritional Status | 2 | 2002 | 1606 | 0.080 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 361 | 0.080 |
Why?
|
| Solvents | 1 | 2009 | 302 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2009 | 3038 | 0.080 |
Why?
|
| Mice, Inbred C3H | 3 | 2005 | 964 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2017 | 1636 | 0.080 |
Why?
|
| Anilides | 2 | 2017 | 404 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 644 | 0.080 |
Why?
|
| Prostatism | 1 | 2007 | 14 | 0.080 |
Why?
|
| Cell Line | 5 | 2020 | 15994 | 0.080 |
Why?
|
| Keratinocytes | 1 | 2012 | 797 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 5724 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2016 | 2036 | 0.080 |
Why?
|
| Spermatogenesis | 1 | 2008 | 262 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 754 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 657 | 0.070 |
Why?
|
| Injections | 1 | 2010 | 840 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2010 | 6452 | 0.070 |
Why?
|
| Health Policy | 2 | 2019 | 2657 | 0.070 |
Why?
|
| Cell Division | 2 | 2006 | 4564 | 0.070 |
Why?
|
| Drug Administration Routes | 2 | 2017 | 153 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5062 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 2011 | 683 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 380 | 0.070 |
Why?
|
| Mothers | 1 | 1997 | 2163 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1503 | 0.070 |
Why?
|
| Social Support | 1 | 2016 | 2117 | 0.070 |
Why?
|
| Area Under Curve | 2 | 2014 | 1653 | 0.070 |
Why?
|
| Body Height | 2 | 2007 | 1574 | 0.070 |
Why?
|
| Myogenin | 1 | 2006 | 58 | 0.070 |
Why?
|
| Breast Feeding | 1 | 1995 | 1339 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.070 |
Why?
|
| United States Food and Drug Administration | 2 | 2017 | 1581 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2017 | 2941 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 438 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 379 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 3766 | 0.070 |
Why?
|
| Respiration | 1 | 2012 | 1645 | 0.070 |
Why?
|
| Dementia | 1 | 2020 | 2501 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 3770 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 4250 | 0.070 |
Why?
|
| Pressure | 1 | 2009 | 1203 | 0.070 |
Why?
|
| Nitriles | 2 | 2017 | 952 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1158 | 0.070 |
Why?
|
| Health Surveys | 4 | 2020 | 4030 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2896 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 35342 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 283 | 0.070 |
Why?
|
| Aorta | 1 | 2013 | 2057 | 0.070 |
Why?
|
| Longitudinal Studies | 7 | 2020 | 13921 | 0.060 |
Why?
|
| Internet | 1 | 2017 | 3062 | 0.060 |
Why?
|
| Transaminases | 1 | 2006 | 199 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 786 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 423 | 0.060 |
Why?
|
| Analgesics, Opioid | 3 | 2017 | 3667 | 0.060 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2004 | 11 | 0.060 |
Why?
|
| Depression | 3 | 2020 | 7733 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 926 | 0.060 |
Why?
|
| Goals | 1 | 2010 | 705 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15530 | 0.060 |
Why?
|
| Military Personnel | 1 | 2013 | 1132 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2011 | 4013 | 0.060 |
Why?
|
| Tyrosine | 1 | 2009 | 1460 | 0.060 |
Why?
|
| Biopsy | 2 | 2007 | 6756 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 319 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2282 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2015 | 112 | 0.060 |
Why?
|
| Hospitalization | 2 | 2022 | 10232 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2009 | 692 | 0.060 |
Why?
|
| Sweden | 2 | 2021 | 1343 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2107 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2012 | 3913 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4455 | 0.060 |
Why?
|
| Health Personnel | 1 | 2017 | 3210 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 814 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 1255 | 0.060 |
Why?
|
| Outpatients | 1 | 2011 | 1483 | 0.060 |
Why?
|
| Protein Transport | 2 | 2008 | 1988 | 0.060 |
Why?
|
| Chromosomes, Human, X | 2 | 2018 | 296 | 0.060 |
Why?
|
| Transdermal Patch | 1 | 2023 | 51 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3133 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 110 | 0.060 |
Why?
|
| Oxymetholone | 1 | 2002 | 9 | 0.060 |
Why?
|
| Appetite | 1 | 2005 | 243 | 0.060 |
Why?
|
| Research | 2 | 2009 | 1999 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2023 | 6587 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2008 | 968 | 0.060 |
Why?
|
| Sampling Studies | 2 | 2001 | 623 | 0.050 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2022 | 63 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2007 | 494 | 0.050 |
Why?
|
| Comorbidity | 3 | 2019 | 10372 | 0.050 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 176 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2007 | 5180 | 0.050 |
Why?
|
| Temperature | 1 | 2009 | 2207 | 0.050 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2004 | 183 | 0.050 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 49 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1737 | 0.050 |
Why?
|
| Tablets | 1 | 2022 | 147 | 0.050 |
Why?
|
| Placebo Effect | 1 | 2006 | 502 | 0.050 |
Why?
|
| Stem Cells | 2 | 2007 | 3563 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3199 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2885 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 141 | 0.050 |
Why?
|
| Weightlessness | 1 | 2002 | 87 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2002 | 59 | 0.050 |
Why?
|
| California | 1 | 2006 | 1400 | 0.050 |
Why?
|
| Lactobacillus casei | 1 | 2001 | 1 | 0.050 |
Why?
|
| Genome-Wide Association Study | 4 | 2018 | 12220 | 0.050 |
Why?
|
| Mesoderm | 1 | 2005 | 686 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 241 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3847 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 1661 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2011 | 1581 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 848 | 0.050 |
Why?
|
| Boston | 2 | 2012 | 9305 | 0.050 |
Why?
|
| Sweating | 1 | 2022 | 123 | 0.050 |
Why?
|
| Phenotype | 3 | 2019 | 16331 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2006 | 637 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3862 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2006 | 739 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2011 | 2049 | 0.050 |
Why?
|
| Diarrhea, Infantile | 1 | 2001 | 109 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 15494 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 778 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 643 | 0.050 |
Why?
|
| Child | 8 | 2009 | 77478 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 7988 | 0.050 |
Why?
|
| Behavior | 1 | 2004 | 560 | 0.050 |
Why?
|
| Drug Monitoring | 2 | 2017 | 956 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 1872 | 0.050 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 19862 | 0.050 |
Why?
|
| Circadian Rhythm | 3 | 2007 | 2623 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2008 | 1151 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1184 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3151 | 0.050 |
Why?
|
| Wound Healing | 1 | 2012 | 2781 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2011 | 8436 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 1071 | 0.050 |
Why?
|
| Neurotic Disorders | 1 | 2000 | 79 | 0.050 |
Why?
|
| Space Flight | 1 | 2002 | 184 | 0.050 |
Why?
|
| Apolipoprotein C-III | 1 | 2002 | 202 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 373 | 0.050 |
Why?
|
| Smoking | 2 | 2018 | 8969 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2021 | 468 | 0.050 |
Why?
|
| Receptor Cross-Talk | 2 | 2012 | 118 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2003 | 40955 | 0.050 |
Why?
|
| Baltimore | 1 | 2020 | 231 | 0.040 |
Why?
|
| Men's Health | 1 | 2020 | 73 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21719 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2001 | 273 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 3957 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4434 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 9826 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2011 | 361 | 0.040 |
Why?
|
| Hot Flashes | 1 | 2022 | 316 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.040 |
Why?
|
| Ion Channels | 2 | 2015 | 1056 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 736 | 0.040 |
Why?
|
| Peptides | 1 | 2011 | 4392 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2021 | 689 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1167 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4553 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 2019 | 132 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1640 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4775 | 0.040 |
Why?
|
| Skin | 1 | 2012 | 4353 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 413 | 0.040 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 995 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2015 | 2536 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 628 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5304 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1107 | 0.040 |
Why?
|
| Medical Assistance | 1 | 2018 | 104 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 4328 | 0.040 |
Why?
|
| Aminophenols | 1 | 2017 | 78 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 2018 | 377 | 0.040 |
Why?
|
| Health | 2 | 2011 | 390 | 0.040 |
Why?
|
| Gender Identity | 1 | 2023 | 681 | 0.040 |
Why?
|
| Communications Media | 1 | 2017 | 43 | 0.040 |
Why?
|
| Ovary | 2 | 2015 | 981 | 0.040 |
Why?
|
| Phytoestrogens | 1 | 2017 | 61 | 0.040 |
Why?
|
| Needs Assessment | 2 | 2016 | 1146 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2018 | 370 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 825 | 0.040 |
Why?
|
| Pregnancy | 3 | 2021 | 29087 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5851 | 0.040 |
Why?
|
| Adenine | 1 | 2021 | 936 | 0.030 |
Why?
|
| Isoflavones | 1 | 2017 | 139 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 2536 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 571 | 0.030 |
Why?
|
| Acetamides | 1 | 2017 | 249 | 0.030 |
Why?
|
| Leptin | 1 | 2004 | 1593 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 425 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18006 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2016 | 9846 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 2017 | 342 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 1574 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 802 | 0.030 |
Why?
|
| Sex Reassignment Procedures | 1 | 2016 | 50 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 552 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2022 | 1548 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2003 | 1806 | 0.030 |
Why?
|
| Estrous Cycle | 1 | 2015 | 73 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2010 | 4229 | 0.030 |
Why?
|
| Educational Status | 1 | 2003 | 2533 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 2018 | 527 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Urban Health | 1 | 1997 | 547 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2019 | 607 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2018 | 436 | 0.030 |
Why?
|
| Weaning | 1 | 1995 | 105 | 0.030 |
Why?
|
| Infant | 5 | 2001 | 35070 | 0.030 |
Why?
|
| ROC Curve | 2 | 2014 | 3528 | 0.030 |
Why?
|
| Sound Spectrography | 1 | 2015 | 117 | 0.030 |
Why?
|
| Geriatrics | 1 | 2019 | 396 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 764 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 1525 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1357 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 7770 | 0.030 |
Why?
|
| Decision Making | 1 | 2008 | 3869 | 0.030 |
Why?
|
| Diabetic Foot | 1 | 2018 | 352 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 1996 | 281 | 0.030 |
Why?
|
| Vasodilation | 1 | 2018 | 944 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 29010 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7873 | 0.030 |
Why?
|
| Triglycerides | 1 | 2002 | 2450 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2013 | 116 | 0.030 |
Why?
|
| Forecasting | 1 | 2003 | 2948 | 0.030 |
Why?
|
| Sample Size | 1 | 2017 | 844 | 0.030 |
Why?
|
| Starvation | 1 | 2013 | 134 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 408 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2016 | 645 | 0.030 |
Why?
|
| Health Priorities | 1 | 2016 | 379 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2014 | 257 | 0.030 |
Why?
|
| Self Concept | 1 | 2018 | 1025 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 963 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 2966 | 0.030 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 53 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2014 | 383 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Voice Disorders | 1 | 2015 | 276 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 936 | 0.020 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2011 | 63 | 0.020 |
Why?
|
| Drug Approval | 1 | 2017 | 740 | 0.020 |
Why?
|
| Genotype | 2 | 2018 | 12946 | 0.020 |
Why?
|
| Rats | 4 | 2011 | 24265 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 2010 | 113 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
| Heart Rate | 2 | 2014 | 4091 | 0.020 |
Why?
|
| Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2011 | 377 | 0.020 |
Why?
|
| Alleles | 2 | 2012 | 6931 | 0.020 |
Why?
|
| Mental Recall | 1 | 2017 | 1205 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.020 |
Why?
|
| Age Distribution | 2 | 2006 | 2900 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 151 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 3504 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2451 | 0.020 |
Why?
|
| Social Class | 2 | 2007 | 1995 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 13814 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 257 | 0.020 |
Why?
|
| Scopolamine | 1 | 1990 | 99 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2723 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 1080 | 0.020 |
Why?
|
| Leucine | 1 | 2011 | 560 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 760 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 235 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 2009 | 106 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2014 | 6191 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77098 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 401 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 563 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 732 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6096 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 415 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 1282 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2017 | 1368 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1411 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 782 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2011 | 386 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2010 | 244 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2008 | 253 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2000 | 1904 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 301 | 0.020 |
Why?
|
| Premenopause | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Glucagon | 1 | 2009 | 533 | 0.020 |
Why?
|
| Memory | 1 | 2017 | 2163 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 830 | 0.020 |
Why?
|
| Epididymis | 1 | 2008 | 227 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3656 | 0.020 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2007 | 177 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 2008 | 474 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 345 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 314 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8300 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1417 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1995 | 0.020 |
Why?
|
| Anxiety | 1 | 2020 | 4279 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 517 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2017 | 6440 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2020 | 5100 | 0.020 |
Why?
|
| Postural Balance | 1 | 2010 | 620 | 0.020 |
Why?
|
| Dexamethasone | 2 | 2003 | 1949 | 0.020 |
Why?
|
| Laboratories | 1 | 2009 | 461 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 800 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4567 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2266 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9639 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1887 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2005 | 151 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 1995 | 25575 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1707 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1827 | 0.020 |
Why?
|
| Poverty | 1 | 1996 | 2646 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2008 | 625 | 0.020 |
Why?
|
| Vitamin D | 1 | 2018 | 3211 | 0.020 |
Why?
|
| Rural Population | 1 | 1994 | 2207 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2020 | 4551 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 502 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
| Myoblasts | 1 | 2005 | 238 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2699 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5948 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 1961 | 0.010 |
Why?
|
| Azacitidine | 1 | 2005 | 347 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6974 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 950 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3923 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1727 | 0.010 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2002 | 30 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 150 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 7716 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6115 | 0.010 |
Why?
|
| Video Recording | 1 | 2007 | 944 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2585 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 862 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2417 | 0.010 |
Why?
|
| Yogurt | 1 | 2001 | 72 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 302 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20086 | 0.010 |
Why?
|
| Algorithms | 2 | 2014 | 13853 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 547 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5454 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.010 |
Why?
|
| Stroke | 1 | 2023 | 9963 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2915 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1581 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2004 | 1613 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2749 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 4961 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 770 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 723 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9679 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9387 | 0.010 |
Why?
|
| Milk | 1 | 2001 | 449 | 0.010 |
Why?
|
| Psychology | 1 | 2000 | 355 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2335 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2002 | 1099 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17400 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 1470 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3339 | 0.010 |
Why?
|
| Immune System | 1 | 2002 | 804 | 0.010 |
Why?
|
| Fasting | 1 | 2002 | 1589 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 1996 | 72 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3444 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4465 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12344 | 0.010 |
Why?
|
| Food, Fortified | 1 | 1996 | 191 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2007 | 3801 | 0.010 |
Why?
|
| DNA | 1 | 2009 | 7289 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2009 | 6078 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2009 | 4030 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 4983 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 12797 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 12242 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2010 | 5774 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 8297 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1990 | 671 | 0.000 |
Why?
|